These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6134661)

  • 21. Neuroleptic catatonia and its relationship to psychogenic catatonia.
    Fricchione GL
    Biol Psychiatry; 1985 Mar; 20(3):304-13. PubMed ID: 2858225
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Catatonia and NMS.
    Tan TK; Ong SH
    Br J Psychiatry; 1991 Jun; 158():858-9. PubMed ID: 1678667
    [No Abstract]   [Full Text] [Related]  

  • 23. Catatonic variants, hyperthermic extrapyramidal reactions, and subtypes of neuroleptic malignant syndrome.
    Lee JW
    Ann Clin Psychiatry; 2007; 19(1):9-16. PubMed ID: 17453656
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drug-induced catatonia.
    Duggal HS; Singh I
    Drugs Today (Barc); 2005 Sep; 41(9):599-607. PubMed ID: 16341291
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Catatonia, neuroleptics and brain damage--a case report.
    Chandran M; El-Shazly M
    J Psychopharmacol; 2009 Mar; 23(2):223-6. PubMed ID: 18562406
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Lethal catatonia and its differential diagnosis with the neuroleptic malignant syndrome].
    Andreu Giménez L; Robert Gates J; Jover Díaz F; Pagán Acosta G; Merino Sánchez J
    Rev Neurol; 2002 Feb 16-28; 34(4):399-400. PubMed ID: 12022063
    [No Abstract]   [Full Text] [Related]  

  • 27. Neuroleptic malignant syndrome.
    Longhurst JG
    Br J Psychiatry; 1995 Apr; 166(4):537-8. PubMed ID: 7795930
    [No Abstract]   [Full Text] [Related]  

  • 28. Treatment of neuroleptic malignant syndrome with dopamine hydrochloride: a case report.
    Ungvari GA
    Pharmacopsychiatry; 1987 May; 20(3):120-1. PubMed ID: 2885866
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Catatonia and mild neuroleptic malignant syndrome after initiation of long-acting injectable risperidone: case report.
    Mall GD; Hake L; Benjamin AB; Adityanjee A
    J Clin Psychopharmacol; 2008 Oct; 28(5):572-3. PubMed ID: 18794658
    [No Abstract]   [Full Text] [Related]  

  • 30. Catatonia in psychiatric classification.
    Van Den Eede F; Sabbe B
    Am J Psychiatry; 2004 Dec; 161(12):2327-8; author reply 2328. PubMed ID: 15569914
    [No Abstract]   [Full Text] [Related]  

  • 31. Neuroleptic-induced catatonia or a mild form of neuroleptic malignant syndrome?
    Kontaxakis VP; Vaidakis NM; Christodoulou GN; Valergaki HC
    Neuropsychobiology; 1990; 23(1):38-40. PubMed ID: 2280828
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Catatonia as a risk factor for the development of neuroleptic malignant syndrome: report of a case following treatment with clozapine.
    Paparrigopoulos T; Tzavellas E; Ferentinos P; Mourikis I; Liappas J
    World J Biol Psychiatry; 2009; 10(1):70-3. PubMed ID: 19673089
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuroleptic-induced extrapyramidal symptoms with fever. Heterogeneity of the 'neuroleptic malignant syndrome'.
    Levinson DF; Simpson GM
    Arch Gen Psychiatry; 1986 Sep; 43(9):839-48. PubMed ID: 2875701
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Atypical neuroleptic malignant syndrome in an adolescent.
    Rais AR; Kimmel S; Shrestha N; Rais TB; Coffey BJ
    J Child Adolesc Psychopharmacol; 2008 Apr; 18(2):215-20. PubMed ID: 18439120
    [No Abstract]   [Full Text] [Related]  

  • 35. [Catatonia and neuroleptic malignant syndrome: two disorders on a same spectrum? Three case reports].
    Luchini F; Lattanzi L; Bartolommei N; Cosentino L; Casamassima F; Litta A; Mauri M; Cassano GB
    Riv Psichiatr; 2012; 47(2):178-85. PubMed ID: 22622253
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Catatonia and neuroleptic malignant syndrome in a mentally retarded patient].
    Heikkilä J; Raitasuo S; Lauerma H; Mölsä P
    Duodecim; 1992; 108(12):1120-4. PubMed ID: 1366062
    [No Abstract]   [Full Text] [Related]  

  • 37. Neuroleptic malignant syndrome and lethal catatonia.
    Munoz RA
    Am J Psychiatry; 1987 Oct; 144(10):1369-70. PubMed ID: 2889379
    [No Abstract]   [Full Text] [Related]  

  • 38. The neuroleptic malignant syndrome--a review.
    Gibb WR; Lees AJ
    Q J Med; 1985 Aug; 56(220):421-9. PubMed ID: 2864716
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Catatonic Symptoms Appearing before Autonomic Symptoms Help Distinguish Neuroleptic Malignant Syndrome from Malignant Catatonia.
    Komatsu T; Nomura T; Takami H; Sakamoto S; Mizuno K; Sekii H; Hatta K; Sugita M
    Intern Med; 2016; 55(19):2893-2897. PubMed ID: 27725556
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lethal catatonia and neuroleptic malignant syndrome. A dopamine receptor shut-down hypothesis.
    Osman AA; Khurasani MH
    Br J Psychiatry; 1994 Oct; 165(4):548-50. PubMed ID: 7804674
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.